Thrive Capital Management (Pennsylvania)’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$427K Hold
2,900
0.09% 131
2025
Q4
$565K Sell
2,900
-381
-12% -$90.7K 0.13% 126
2025
Q3
$923K Sell
3,281
-1
-0% -$255 0.24% 105
2025
Q2
$718K Buy
3,282
+681
+26% +$110K 0.22% 111
2025
Q1
$364K Buy
+2,601
New +$423K 0.22% 92
2024
Q4
Sell
-2,793
Closed -$476K 150
2024
Q3
$476K Sell
2,793
-278
-9% -$40.3K 0.22% 126
2024
Q2
$434K Buy
3,071
+31
+1% +$3.85K 0.2% 134
2024
Q1
$382K Sell
3,040
-1,418
-32% -$162K 0.2% 67
2023
Q4
$470K Buy
4,458
+595
+15% +$64.9K 0.25% 65
2023
Q3
$409K Buy
3,863
+174
+5% +$20.1K 0.23% 74
2023
Q2
$439K Buy
3,689
+1,034
+39% +$107K 0.25% 66
2023
Q1
$240K Buy
+2,655
New +$233K 0.15% 110
2022
Q2
Sell
-2,439
Closed -$202K 113
2022
Q1
$202K Buy
+2,439
New +$198K 0.12% 97

Other funds holding ORCL

Thrive Capital Management (Pennsylvania)'s ORCL Position: Q1 2026 in Review

Thrive Capital Management (Pennsylvania) held its Oracle (ORCL) position steady in Q1 2026 at 2,900 shares worth $427K. The position accounts for 0.09% of the portfolio, ranked #131.

Thrive Capital Management (Pennsylvania) first reported a position in ORCL in Q1 2022 and has held it in 13 quarters since. The position peaked at $923K in Q3 2025. 3,475 funds tracked by Wall St. Rank hold ORCL as of Q1 2026.

  • Thrive Capital Management (Pennsylvania) held 2,900 shares of Oracle worth $427K as of Q1 2026.
  • Thrive Capital Management (Pennsylvania) left its Oracle share count unchanged in Q1 2026.
  • Oracle made up 0.09% of Thrive Capital Management (Pennsylvania)'s portfolio in Q1 2026, its #131 holding.
  • Thrive Capital Management (Pennsylvania) first reported a position in Oracle in Q1 2022 and has held it in 13 quarters since.
  • Thrive Capital Management (Pennsylvania)'s Oracle position peaked at $923K in Q3 2025.
  • 3,475 funds tracked by Wall St. Rank held Oracle as of Q1 2026.

Based on Thrive Capital Management (Pennsylvania)'s 13F filing for Q1 2026, filed 27 Apr 2026.